glp 1 agonist benefits The expanding of GLP-1 medicines: Cell Reports Medicine 8 Benefits of GLP‑1's Beyond

Studies have demonstrated that liraglutide significantly impairs colorectal cancer cell migration, invasion, and proliferation by inhibiting the PI3K/Akt/mTOR signaling pathway, while concurrently promoting tumor cell apoptosis [77]

By week 12, approximately 85% of users report minimal to no ongoing side effects

J., Bleich, S

Long-term conclusions rely on extrapolation Marie Spreckley, obesity researcher and public health nutritionist at the University of Cambridge in England, who was not involved in the study, cautioned that the papers long-term conclusions rely on modeled projections, rather than observed data, as the follow-up period for stopping treatment with newer medicines is limited to about 12 months